Pierre Wolkenstein
#126,288
Most Influential Person Now
Researcher ORCID ID = 0000-0001-8194-457X
Pierre Wolkenstein's AcademicInfluence.com Rankings
Pierre Wolkensteinbiology Degrees
Biology
#8007
World Rank
#11015
Historical Rank
Cell Biology
#306
World Rank
#314
Historical Rank
Genetics
#783
World Rank
#875
Historical Rank
Molecular Biology
#976
World Rank
#1000
Historical Rank
Download Badge
Biology
Pierre Wolkenstein's Degrees
- PhD Biomedical Sciences Université Paris Cité
Why Is Pierre Wolkenstein Influential?
(Suggest an Edit or Addition)Pierre Wolkenstein's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- [Centers for Disease Control and Prevention (CDC)]. (2000) (2883)
- SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. (2000) (914)
- Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. (2008) (551)
- Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis (1998) (397)
- Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. (2004) (356)
- Quality of life impairment in hidradenitis suppurativa: a study of 61 cases. (2007) (346)
- Patch testing in severe cutaneous adverse drug reactions, including Stevens‐Johnson syndrome and toxic epidermal necrolysis (1996) (313)
- Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis (1996) (294)
- Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study (2008) (281)
- Severe cutaneous adverse reactions to drugs (2017) (275)
- Elevated risk for MPNST in NF1 microdeletion patients. (2003) (273)
- Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. (2003) (239)
- Neurological complications of neurofibromatosis type 1 in adulthood. (1999) (236)
- Association between benign and malignant peripheral nerve sheath tumors in NF1 (2005) (236)
- Combination Therapy with Clindamycin and Rifampicin for Hidradenitis Suppurativa: A Series of 116 Consecutive Patients (2009) (235)
- Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. (2000) (227)
- Clinical and genetic studies of Birt-Hogg-Dubé syndrome (2002) (224)
- NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype (2010) (224)
- Open trial of ciclosporin treatment for Stevens–Johnson syndrome and toxic epidermal necrolysis (2010) (221)
- Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. (2001) (193)
- Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study. (2013) (191)
- Motor cortex stimulation for the treatment of refractory peripheral neuropathic pain. (2009) (179)
- HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis (2013) (175)
- Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. (2009) (170)
- Delays in diagnosis and melanoma prognosis (I): The role of patients (2000) (159)
- Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. (1995) (148)
- Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation (2021) (148)
- Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study (1997) (143)
- A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome. (1995) (139)
- Neurofibromatosis type 1: from genotype to phenotype (2012) (139)
- NF1 Molecular Characterization and Neurofibromatosis Type I Genotype–Phenotype Correlation: The French Experience (2013) (138)
- Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). (2002) (133)
- Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. (2009) (129)
- Impact of neurofibromatosis 1 on Quality of Life: A cross‐sectional study of 176 American cases (2006) (127)
- French people and skin diseases: results of a survey using a representative sample. (2003) (122)
- Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa. (2016) (119)
- Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients (2013) (117)
- Acne prevalence and associations with lifestyle: a cross‐sectional online survey of adolescents/young adults in 7 European countries (2018) (115)
- Face transplant: long-term follow-up and results of a prospective open study (2016) (114)
- Delays in diagnosis and melanoma prognosis (II): The role of doctors (2000) (114)
- Therapeutic management of DRESS: a retrospective study of 38 cases. (2015) (113)
- Melanoma and tumor thickness: challenges of early diagnosis. (1999) (113)
- Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta‐analysis of observational studies (2015) (110)
- Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. (2011) (108)
- Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. (2017) (106)
- Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes (2020) (106)
- Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1 (2005) (105)
- Linear IgA bullous dermatosis: comparison between the drug‐induced and spontaneous forms (2013) (105)
- Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. (2001) (103)
- SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype (2009) (99)
- Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France (2011) (98)
- Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study (2015) (96)
- Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist? (2012) (95)
- Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR (2004) (94)
- Drug-Induced Severe Skin Reactions (1995) (93)
- Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations? (2014) (90)
- Absence of Efficacy of Oral Isotretinoin in Hidradenitis Suppurativa: A Retrospective Study Based on Patients’ Outcome Assessment (2008) (88)
- Reliability of the histopathologic diagnosis of malignant melanoma in childhood. (2002) (82)
- Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancérologie Cutanée. (1998) (81)
- Psoriasis in France and Associated Risk Factors: Results of a Case-Control Study Based on a Large Community Survey (2008) (78)
- Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: A cohort study of 703 patients (2005) (75)
- Drug‐induced linear IgA disease: target antigens are heterogeneous (1997) (75)
- Intestinal involvement in drug-induced toxic epidermal necrolysis (1991) (71)
- Vulvovaginal Involvement in Toxic Epidermal Necrolysis: A Retrospective Study of 40 Cases (1998) (70)
- Bacteremia in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Epidemiology, Risk Factors, and Predictive Value of Skin Cultures (2010) (70)
- Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review (2013) (70)
- Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966 (2020) (69)
- Acute Respiratory Failure in Patients With Toxic Epidermal Necrolysis: Clinical Features and Factors Associated With Mechanical Ventilation* (2014) (68)
- Most chilblains observed during the COVID‐19 outbreak occur in patients who are negative for COVID‐19 on polymerase chain reaction and serology testing* (2020) (68)
- Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population (2008) (67)
- The role of prior corticosteroid use on the clinical course of Stevens–Johnson syndrome and toxic epidermal necrolysis: a case–control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies (2012) (66)
- PTCH mutations and deletions in patients with typical nevoid basal cell carcinoma syndrome and in patients with a suspected genetic predisposition to basal cell carcinoma: a French study (2006) (64)
- Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS. (2002) (63)
- Comparison of Systematic Versus Selective Screening for Methicillin-Resistant Staphylococcus aureus Carriage in a High-Risk Dermatology Ward (2000) (62)
- Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study. (2015) (62)
- Evolving Pattern with Age of Cutaneous Signs in Neurofibromatosis Type 1: A Cross-Sectional Study of 728 Patients (2011) (61)
- Health-Related Quality of Life in Patients with Neurofibromatosis Type 1 (2008) (60)
- Drug-induced toxic epidermal necrolysis. (1998) (60)
- Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients. (1996) (60)
- Neurofibromatosis 1-associated neuropathies: a reappraisal. (2004) (60)
- mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma. (2014) (60)
- Association Between Mediterranean Anti-inflammatory Dietary Profile and Severity of Psoriasis: Results From the NutriNet-Santé Cohort (2018) (58)
- The kinetics of the visible growth of a primary melanoma reflects the tumor aggressiveness and is an independent prognostic marker: A prospective study (2002) (57)
- Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin. (1998) (57)
- Impact of neurofibromatosis 1 upon quality of life in childhood: a cross‐sectional study of 79 cases (2009) (57)
- Histiocytoid Sweet Syndrome Is More Frequently Associated With Myelodysplastic Syndromes Than the Classical Neutrophilic Variant (2016) (52)
- Microarray-Based Identification of Tenascin C and Tenascin XB, Genes Possibly Involved in Tumorigenesis Associated with Neurofibromatosis Type 1 (2007) (51)
- Consequences of acne on stress, fatigue, sleep disorders and sexual activity: a population-based study. (2015) (49)
- Smoking and Dietary Factors Associated with Moderate-to-Severe Acne in French Adolescents and Young Adults: Results of a Survey Using a Representative Sample (2014) (48)
- Cutaneous malignant melanoma and neurofibromatosis type 1 (2004) (48)
- Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France (2020) (47)
- Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patients. (2003) (46)
- Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1 (2014) (46)
- MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis (2013) (46)
- First-line treatment of pemphigus vulgaris with a combination of rituximab and high-potency topical corticosteroids. (2015) (45)
- Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells (2016) (45)
- Hepatitis C virus infection in cutaneous polyarteritis nodosa: a retrospective study of 16 cases. (1999) (45)
- Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome (2020) (44)
- Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients. (2015) (44)
- Identification of Genes Potentially Involved in the Increased Risk of Malignancy in NF1-Microdeleted Patients (2011) (44)
- Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins) (2018) (44)
- Back and Face Involvement in Hidradenitis Suppurativa (2010) (44)
- The Activation of the WNT Signaling Pathway Is a Hallmark in Neurofibromatosis Type 1 Tumorigenesis (2013) (43)
- The science of dermocosmetics and its role in dermatology (2014) (43)
- More on the frequency of segmental neurofibromatosis. (1995) (42)
- Poor Reporting of Quality of Life Outcomes in Dermatology Randomized Controlled Clinical Trials (2007) (41)
- Cutaneous side effects associated with interleukin 2 administration for metastatic melanoma. (1993) (40)
- Cutaneous neurofibromas (2018) (40)
- Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk. (2009) (40)
- Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDS. (2000) (40)
- Minocycline-Induced DRESS: Evidence for Accumulation of the Culprit Drug (2008) (40)
- Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults (2017) (39)
- Amicrobial pustulosis associated with autoimmune diseases: healing with zinc supplementation (2000) (38)
- Clinical and histologic features of Mycoplasma pneumoniae–related erythema multiforme: A single‐center series of 33 cases compared with 100 cases induced by other causes (2018) (37)
- A survey on the prevalence of orofacial herpes in France: the INSTANT Study. (2006) (37)
- Development and validation of a questionnaire to evaluate how a cosmetic product for oily skin is able to improve well‐being in women (2007) (37)
- Vulvovaginal sequelae in toxic epidermal necrolysis. (1997) (37)
- Positive regulation of apoptosis by HCA66, a new Apaf-1 interacting protein, and its putative role in the physiopathology of NF1 microdeletion syndrome patients (2007) (37)
- Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched Analyses. (2018) (36)
- Detection and characterization of NF1 microdeletions by custom high resolution array CGH. (2009) (36)
- NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1. (2010) (35)
- Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker. (2015) (35)
- Prognostic value of histologic features of toxic epidermal necrolysis. (2013) (34)
- Stevens-Johnson syndrome and toxic epidermal necrolysis: ear, nose, and throat description at acute stage and after remission. (2015) (33)
- Cost evaluation of the medical management of neurofibromatosis 1: a prospective study on 201 patients (2000) (33)
- Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with Nf1 Knockout in Boundary Cap Cells. (2018) (32)
- Localized pretibial pemphigoid and pemphigoid nodularis. (1992) (32)
- Molecular Profiles of Neurofibromatosis Type 1-Associated Plexiform Neurofibromas (2004) (32)
- Acute generalized exanthematous pustulosis: a retrospective audit of practice between 1994 and 2011 at a single centre (2015) (32)
- Dermatological emergencies: a comparative study of activity in 2000 and 2010 (2013) (31)
- The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations. (2006) (30)
- Cutaneous neuro fi bromas Current clinical and pathologic issues (29)
- Different Patterns of Mast Cells Distinguish Diffuse from Encapsulated Neurofibromas in Patients with Neurofibromatosis 1 (2011) (29)
- Histopathologically dysplastic neurofibromas in neurofibromatosis 1: diagnostic criteria, prevalence and clinical significance (2008) (29)
- Post‐traumatic stress disorder in Stevens–Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients (2018) (28)
- Sirolimus Improves Pain in NF1 Patients With Severe Plexiform Neurofibromas (2014) (28)
- Carbon dioxide laser for removal of multiple cutaneous neurofibromas (2001) (27)
- Toxic epidermal necrolysis. (2000) (27)
- Treatment of prurigo with methotrexate: a multicentre retrospective study of 39 cases (2018) (26)
- Schwannomatosis: a clinical entity distinct from neurofibromatosis type 2. (1997) (26)
- Facial aesthetic unit remodeling procedure for neurofibromatosis type 1 hemifacial hypertrophy: report on 33 consecutive adult patients. (2010) (26)
- Factors associated with postoperative complications in elderly patients with skin cancer: A retrospective study of 241 patients. (2016) (26)
- Stevens–Johnson syndrome and toxic epidermal necrolysis: follow‐up of pulmonary function after remission (2015) (25)
- Incidence of and mortality from epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) in France during 2003–16: a four‐source capture–recapture estimate (2020) (25)
- Clinical Characteristics of Pruritus in Neurofibromatosis 1. (2016) (25)
- [Neurofibromatosis 1: recommendations for management]. (2001) (25)
- Lack of Association between CARD15 Gene Polymorphisms and Hidradenitis Suppurativa: A Pilot Study (2007) (25)
- Hair follicle stem cell replication stress drives IFI16/STING-dependent inflammation in hidradenitis suppurativa. (2020) (24)
- Health‐related quality of life and long‐term sequelae in survivors of epidermal necrolysis: an observational study of 57 patients (2020) (24)
- PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens (2019) (24)
- Association analysis of drug metabolizing enzyme gene polymorphisms in AIDS patients with cutaneous reactions to sulfonamides. (2005) (23)
- French referral center management of Stevens–Johnson syndrome/toxic epidermal necrolysis (2013) (23)
- Efficacy and satisfaction of surgical treatment for hidradenitis suppurativa (2019) (23)
- The Value of BP230 Enzyme-Linked Immunosorbent Assay in the Diagnosis and Immunological Follow-Up of Bullous Pemphigoid (2012) (23)
- Cutaneous macroglobulinosis: a report of 2 cases. (2010) (23)
- Treatment of Neurofibromas with a Carbon Dioxide Laser: A Retrospective Cross-Sectional Study of 106 Patients (2015) (23)
- Patch testing in non‐immediate cutaneous adverse drug reactions: value of extemporaneous patch tests (2017) (22)
- Breast cancer risk in neurofibromatosis type 1 is a function of the type of NF1 gene mutation: a new genotype-phenotype correlation (2018) (22)
- Antiproliferative effect of semaphorin 3F on human melanoma cell lines. (2006) (22)
- Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1 (2016) (21)
- Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study (2019) (21)
- [Blue-red macules and pseudoatrophic macules in neurofibromatosis 1]. (2002) (20)
- At-Risk Phenotype of Neurofibromatose-1 Patients: A Multicentre Case-Control Study (2011) (20)
- Association Between Severe Acute Contact Dermatitis Due to Nigella sativa Oil and Epidermal Apoptosis (2018) (20)
- [Neurofibromatosis type 1 or Von Recklinghausen's disease]. (2005) (20)
- Visibility of neurofibromatosis 1 and psychiatric morbidity. (2003) (20)
- Lichenoid erythrodermic bullous pemphigoid of the African patient. (1998) (20)
- A French CDK4-positive melanoma family with a co-inherited EDNRB mutation. (2007) (19)
- [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review]. (2011) (19)
- [Antiseptics in skin diseases]. (1996) (19)
- Pulmonary embolism; lung scanning interpretation: about words. (1998) (19)
- Clinical characteristics predicting internal neurofibromas in 357 children with neurofibromatosis-1: results from a cross-selectional study (2012) (19)
- Severe cutaneous adverse reactions due to inappropriate medication use (2018) (19)
- Levetiracetam: a possible new inducer of toxic epidermal necrolysis and Stevens-Johnson syndrome in 2 cases. (2013) (19)
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases (2011) (18)
- The biology of cutaneous neurofibromas (2018) (18)
- Dermatological emergencies: evolution from 2008 to 2014 and perspectives (2017) (18)
- Evaluation of Skin Viscoelasticity in Type 1 Neurofibromatosis Patients (2005) (18)
- Absence of Efficacy of Everolimus in Neurofibromatosis 1-Related Plexiform Neurofibromas: Results from a Phase 2a Trial. (2019) (18)
- Antitumour necrosis factor‐α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013 (2016) (17)
- Trends in mortality rates for Stevens–Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017 (2019) (17)
- Contact dermatitis caused by ascorbyl tetraisopalmitate in a cream used for the management of atopic dermatitis (2014) (17)
- Positive Direct Immunofluorescence Is of Better Value than ELISA-BP180 and ELISA-BP230 Values for the Prediction of Relapse after Treatment Cessation in Bullous Pemphigoid: A Retrospective Study of 97 Patients (2015) (17)
- Caseous necrosis in cutaneous leishmaniasis. (1996) (17)
- The biology of cutaneous neuro fi bromas Consensus recommendations for setting research priorities (17)
- Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. (2022) (17)
- Cold‐associated perniosis of the thighs histopathologically mimicking lupus. Six observations (2017) (16)
- Current status and recommendations for biomarkers and biobanking in neurofibromatosis (2016) (16)
- Toxic epidermal necrolysis after fluvoxamine (1993) (16)
- Acne across Europe: an online survey on perceptions and management of acne (2018) (16)
- Differential Expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in Neurofibromatosis Type 1 Tumorigenesis (2010) (15)
- Pemphigus in Elderly Adults: Clinical Presentation, Treatment, and Prognosis (2012) (15)
- Management of Bullous Pemphigoid with Topical Steroids in the Clinical Practice of a Single Center: Outcome at 6 and 12 Months (2011) (15)
- Medical management of neurofibromatosis 1: a cross-sectional study of 383 patients. (2003) (15)
- Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma (2018) (15)
- Treatment of sphenoid dysplasia with a titanium-reinforced porous polyethylene implant in orbitofrontal neurofibroma: report of three cases. (2014) (14)
- [Neurofibromatoses and tuberous sclerosis]. (2005) (14)
- Agreement Between Self-reported Inflammatory Skin Disorders and Dermatologists' Diagnosis: A Cross-sectional Diagnostic Study. (2017) (14)
- Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database (2022) (14)
- Neurofibromatosis 1: Analysis of the demand for prenatal diagnosis in a French cohort of 361 patients (2008) (14)
- [Sarcoidosis: thalidomide treatment in ten patients]. (2001) (14)
- Prevalence and Description of Hidradenitis Suppurativa in Down Syndrome: A Cross-sectional Study of 783 Subjects. (2019) (14)
- Rituximab, a new treatment for difficult‐to‐treat chronic erythema multiforme major? Five cases (2016) (14)
- Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool (2019) (13)
- Individual‐ and hospital‐level factors associated with epidermal necrolysis mortality: a nationwide multilevel study, France, 2012–2016 (2020) (12)
- [Topical antibiotics used in dermatology: efficiency, indications and adverse events]. (2000) (12)
- Aberrant axon neurofilaments in schwannomas associated with phacomatoses (2003) (12)
- [Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation]. (2011) (12)
- HIV-Related CD8+ Cutaneous Pseudolymphoma: Efficacy of Methotrexate (2013) (12)
- Idiopathic Stevens‐Johnson syndrome and toxic epidermal necrolysis: Prevalence and patients' characteristics (2019) (12)
- Severe sequelae of erythema multiforme: three cases (2018) (12)
- NF1 single and multi-exons copy number variations in neurofibromatosis type 1 (2015) (12)
- [The French version of Skindex (Skindex-France). Adaptation and assessment of psychometric properties]. (2003) (12)
- NF1 gene analysis focused on CpG‐rich exons in a cohort of 93 patients with neurofibromatosis type 1 (2000) (12)
- Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes (2018) (12)
- [Large hairy pigmented spots in neurofibromatosis type 1: an atypical form of neurofibromas]. (2001) (11)
- Segmental schwannomatosis: characteristics in 12 patients (2019) (11)
- Heparin-induced hemorrhagic blisters. (2013) (11)
- Cross‐reactivity in beta‐lactams after a non‐immediate cutaneous adverse reaction: experience of a reference centre for toxic bullous diseases and severe cutaneous adverse reactions (2020) (11)
- [Acute mast cell leukemia disclosed by vasomotor flushing]. (1997) (11)
- Acute exanthemas: a prospective study of 98 adult patients with an emphasis on cytokinic and metagenomic investigation (2019) (10)
- Severe Phenotype in Patients with Large Deletions of NF1 (2021) (10)
- Cutaneous lesions in neurofibromatosis 1: confused terminology (2007) (10)
- Supportive care in the acute phase of Stevens–Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi‐based consensus (2021) (10)
- Infection-free Clinical Response Among Patients With Hidradenitis Suppurativa Who Were Treated With Adalimumab: Results from Two Phase 3 Studies. (2017) (10)
- CT detection of an ampullary somatostatinoma in a patient with von Recklinghausen's disease. (1999) (10)
- Incidence of bloodstream infections and predictive value of qualitative and quantitative skin cultures of patients with overlap syndrome or toxic epidermal necrolysis: A retrospective observational cohort study of 98 cases. (2019) (10)
- Management of ocular involvement in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: french national audit of practices, literature review, and consensus agreement (2020) (10)
- Neurofibromatosis type 1: neurofibromas and sex (2016) (10)
- Surgical care burden in orbito-temporal neurofibromatosis: Multiple procedures and surgical care duration analysis in 47 consecutive adult patients. (2015) (9)
- Renal replacement therapy during Stevens–Johnson syndrome and toxic epidermal necrolysis: a retrospective observational study of 238 patients (2017) (9)
- Creating a comprehensive research strategy for cutaneous neurofibromas (2018) (9)
- Cutaneous neurofibromas: patients’ medical burden, current management and therapeutic expectations: results from an online European patient community survey (2019) (9)
- MEK inhibitors in RASopathies (2020) (9)
- Patient-hospital communication: A platform to improve outpatient chemotherapy (2016) (9)
- Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS) (2015) (9)
- Epidemilogy of toxic epidermal necrolysis (1994) (9)
- Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas. (2018) (9)
- Severe contact allergy to mupirocin in a polysensitized patient (2019) (8)
- High-concentration topical capsaicin in the management of refractory neuropathic pain in patients with neurofibromatosis type 1: a case series (2018) (8)
- Toxic epidermal necrolysis after sulfasalazine treatment of mild psoriatic arthritis: warning on the use of sulfasalazine for a new indication. (1995) (8)
- [Cutaneous manifestations of type 1 neurofibromatosis and their treatment]. (1998) (8)
- Bleeding: a complication of neurofibromatosis 1 tumors. (2001) (8)
- Usefulness of Systematic Ophthalmologic Investigations in Neurofibromatosis 1: A Cross-Sectional Study of 211 Patients (2002) (8)
- Disabling ocular sequelae of epidermal necrolysis: risk factors during the acute phase and associated sequelae (2019) (8)
- S100B and neurofibromin immunostaining and X‐inactivation patterns of laser‐microdissected cells indicate a multicellular origin of some NF1‐associated neurofibromas (2011) (7)
- Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1. (2020) (7)
- Chronic pain: a long‐term sequela of epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) – prevalence, clinical characteristics and risk factors (2020) (7)
- [Frequency of plantar dermatophytosis. A retrospective study 2002-2003]. (2007) (7)
- [Treatment of severe cutaneous adverse drug reactions]. (2018) (7)
- Eruption of lymphocyte recovery with atypical lymphocytes mimicking a primary cutaneous T-cell lymphoma: a series of 12 patients. (2018) (7)
- Living with psoriasis (2006) (7)
- Kikuchi Disease-Like Inflammatory Pattern in Cutaneous Inflammatory Infiltrates Without Lymph Node Involvement (2015) (7)
- Gastrointestinal involvement in Stevens–Johnson syndrome and toxic epidermal necrolysis: a retrospective case series (2019) (7)
- A large epidemiological study of erythema multiforme in France, with emphasis on treatment choices (2018) (7)
- Dark skin phototype is associated with more severe ocular complications of Stevens–Johnson syndrome and toxic epidermal necrolysis (2019) (7)
- Toxic epidermal necrolysis: the past, the guidelines and challenges for the future (2016) (7)
- Autoimmune disorders and interleukin-2 therapy: a step toward 'unanswered questions'. (1995) (7)
- Epidermal necrolysis and autoimmune diseases: two more observations supporting the concept that ‘toxic’ epidermal necrolysis can be ‘non‐toxic’ (2018) (7)
- Toxic epidermal necrolysis after paroxetine treatment (1995) (6)
- SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog. (2011) (6)
- Pulmonary cryptococcoma in a patient with Sézary syndrome treated with alemtuzumab. (2011) (6)
- [Acute generalized exanthematous pustulosis induced by iopamidol]. (2004) (6)
- First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics (2019) (6)
- The Value of Anti-Desmoglein Enzyme-Linked Immunosorbent Assay in the Immunological Follow-Up of Pemphigus (2014) (6)
- Febrile ulceronecrotic Mucha Habermann disease mimicking aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: a diagnostic challenge (2018) (6)
- [Melanoma during latanoprost therapy: three cases]. (2009) (6)
- EDNRB gene variants and melanoma risk in two southern European populations (2011) (6)
- Quality of Life in Hidradenitis Suppurativa (2006) (6)
- Nocardia asteroides septicemia in a pemphigus patient. Successful treatment with trimethoprim-sulfamethoxazole and amikacin association. (1990) (5)
- [Activity report on a rapid post-emergency consultation for the management of dermatological emergencies [corrected]]. (2010) (5)
- Dermatomyositis: factors predicting relapse (2016) (5)
- [Psychological impact of neurofibromatosis type 1: the analysis of interviews with 12 patients with regard to an evaluation of the quality of life]. (1999) (5)
- Neurofibromatosis 1 phenotype associated to malignant peripheral nerve sheath tumours: a case‐control study (2013) (5)
- Skin biopsy polymerase chain reaction for rapid microbiological diagnosis in patients with purpura fulminans (2017) (5)
- A process modelling approach to assess the impact of teledermatology deployment onto the skin tumor care pathway (2020) (5)
- [Recommendations for the treatment of neurofibromatosis type 1]. (2002) (5)
- Nodules on the Legs in a Renal Transplant Recipient—Quiz Case (2013) (5)
- Patch tests in nonimmediate cutaneous adverse drug reactions: The importance of late readings on day 4 (2021) (5)
- Traitement des toxidermies graves (2018) (5)
- Interactions between ultraviolet light exposure and DNA repair gene polymorphisms may increase melanoma risk (2009) (5)
- Cutaneous tests and interest of iobitridol in non‐immediate hypersensitivity to contrast media: a case series of 43 patients (2019) (5)
- [Eruptive nevus in the course of Lyell syndrome]. (1995) (5)
- Bladder Dysfunction in Children with Neurofibromatosis Type I: Report of Four Cases and Review of the Literature (2018) (5)
- Neurofibromatosis I and multiple sclerosis (2020) (5)
- [Clinical diagnosis of neurofibromatosis type 1]. (1999) (5)
- Dermatitis herpetiformis and bone mineral density: analysis of a French cohort of 53 patients (2017) (5)
- Epidermolysis bullosa acquisita‐like eruption with anticollagen VII autoantibodies induced by d‐penicillamine in Wilson disease (2014) (5)
- Melanoma susceptibility and progression: Association study between polymorphisms of the chemokine (CCL2) and chemokine receptors (CX3CR1, CCR5). (2007) (5)
- Lenalidomide as an Alternative to Thalidomide for Treatment of Recurrent Erythema Multiforme. (2018) (5)
- Thalidomide in Severe Hidradenitis Suppurativa: A Therapeutic Option. (2019) (5)
- Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases. (2021) (5)
- [Vitiligo-like lesions in melanoma treated with interleukin-2: 4 cases]. (1992) (5)
- [Advances in understanding of the pathophysiology of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis)]. (2020) (4)
- Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study (2021) (4)
- Toxic epidermal necrolysis: The past, the guidelines and challenges for the future. (2016) (4)
- Necrotizing fasciitis of the thigh revealing a Crohn's disease (2015) (4)
- Clinical and histological features of fixed drug eruption: a single-centre series of 73 cases with comparison between bullous and non-bullous forms (2021) (4)
- Low Rates of Blood Transfusion in Elective Resections of Neurofibromas in a Cohort Study: Neurofibroma Length as a Predictor of Transfusion Requirement (2016) (4)
- Age at Diagnosis of Neurofibromatosis 1: An Audit of Practice (2008) (4)
- No association between HLA‐B and cutaneous reactions to sulphonamides in human immunodeficiency virus‐infected patients (2008) (4)
- ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis (2022) (4)
- Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin and pristinamycin: clinical history and patch testing (2018) (4)
- Stevens-Johnson Syndrome During Pregnancy: Case Report of a Newborn Treated With the Culprit Drug. (2017) (4)
- Bone Status According to Neurofibromatosis Type 1 Phenotype: A Descriptive Study of 60 Women in France (2021) (4)
- Allergic emergencies encountered by the dermatologist (1999) (4)
- [Aseptic cutaneous breast abscesses associated with ulcerative colitis]. (2016) (4)
- Lymphoproliferative malignancies in patients with neurofibromatosis 1 (2021) (4)
- A new cause of ‘gloves and socks’ syndrome: chicken pox (2009) (4)
- Facial transplantation: facing the limits, planning the future (2017) (4)
- [The physician-patient relation. Reporting a severe disease. Education of a patient suffering from a chronic disease. Personalizing medical management]. (2002) (4)
- [Cutaneous sarcoidosis: efficacy of KTP laser]. (2007) (4)
- La neurofibromatose 1 (2001) (4)
- Severe Cutaneous Adverse Reactions to Drugs: From Patients to the National Office for Compensation of Medical Accidents (2014) (4)
- Combined Methotrexate and Alitretinoin for the treatment of difficult‐to‐treat generalized prurigo nodularis: a case series (2021) (4)
- Facial Scars following Toxic Epidermal Necrolysis: Role of Adnexal Involvement? (2016) (4)
- [Successful treatment of haemodialysis-related porphyria cutanea tarda with deferoxamine]. (2003) (4)
- Prevalence of fragile skin in Russia (2017) (4)
- Relapsing generalized bullous fixed drug eruption: A severe and avoidable cutaneous drug reaction. Three case reports. (2021) (3)
- Identifying challenges in neurofibromatosis: a modified Delphi procedure (2021) (3)
- Are Idiopathic Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Related to Drugs in Food? The Example of Phenylbutazone. (2017) (3)
- Serotonin transporter gene polymorphism and psychiatric disorders in NF1 patients. (2001) (3)
- Sirolimus Improves Pain in NF 1 Patients With Severe (2014) (3)
- Modifier Genes in NF1 (2012) (3)
- Nodules on the legs in a renal transplant recipient. Deep dermal dermatophytosis caused by Trichophyton rubrum. (2013) (3)
- Strong reactions to diltiazem patch-tests: plea for a low concentration. (2020) (3)
- Dermatological emergency unit, day‐care hospital and consultations in time of COVID‐19: the impact of teledermatology (2021) (3)
- [PRC2 alterations in NF1-associated malignant peripheral nerve sheath tumors: schwann cells with no complex]. (2014) (3)
- Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology (2021) (3)
- A rare cause of acquired telangiectases extending from the feet to arms. (2011) (3)
- A multimethodology for hospital process redesign (2017) (3)
- Very late sensitization to parabens induced by repeated applications of an anaesthetic therapeutic plaster to non‐damaged skin (2018) (3)
- Retinoids 10 Years On (1990) (3)
- Treatment of cutaneous neurofibromas with carbon dioxide laser: Technique and patient experience. (2021) (3)
- [How far can we go in diseases that make life difficult: the example of disfiguring dermatoses]. (2010) (3)
- Epidemiology of fragile skin: Internet-based surveys in Mexico and Russia (2017) (3)
- Pemphigoid gestationis revealing a denial of pregnancy (2016) (3)
- [Profuse scabies: kinetic curves of parasitologic cure with an association of benzyl benzoate and sulfiram]. (2002) (3)
- Acute generalized exanthematous pustulosis and epidermal necrolysis differ in innate cytokine patterns (2019) (3)
- [Cutaneous adverse drug reaction with pulmonary involvement]. (2003) (3)
- Acute generalized exanthematous pustulosis induced by enoxaparin: 2 cases (2020) (2)
- Primary cutaneous mucormycosis as a complication of erosive dermatitis: two cases (2018) (2)
- Changing spectrum of suspected drugs of Epidermal Necrolysis: an WHO pharmacovigilance database analysis from 1997 to 2020. (2020) (2)
- Local antibiotics in dermatology: efficacity, indications, adverse effects. (2000) (2)
- In vitro evaluation of genetic predisposition to toxic epidermal necrolysis (1993) (2)
- Erythema multiforme associated with anti‐plakin antibodies: a multicentric retrospective case series (2022) (2)
- PSN9 PREVALENCE AND QUALITY OF LIFE OF PATIENTS SUFFERING FROM INFLAMMATORY DERMATITIS (PSORIASIS, ECZEMA, ATOPIC DERMATITIS AND URTICARIA) IN FRANCE—INSTANT STUDY (2003) (2)
- Suspected Viral Maculopapular Eruptions: An Audit of Practice (2013) (2)
- Towards a better understanding of adult idiopathic epidermal necrolysis: a retrospective study of 19 cases (2021) (2)
- First case of contact dermatitis caused by hydroxypropyl tetrahydropyrantriol used in an anti‐ageing cream (2017) (2)
- Beard dermatitis induced by coloration (2019) (2)
- Face transplantation: A longitudinal histological study focusing on chronic active and mucosal rejection in a series with long‐term follow‐up (2021) (2)
- NF1 gene analysis focused on CpG-rich exons in a cohort of 93 patients with neurofibromatosis type 1 Communicated by: Jurgen Horst Online Citation: Human Mutation, Mutation in Brief #363 (2000) Online http://journals.wiley.com/1059-7794/pdf/mutation/363.pdf (2000) (2)
- Epidermal necrolysis: characterization of different phenotypes using an unsupervised clustering analysis (2022) (2)
- [Exclusive nodular plexiform neurofibroma. An unusual case of neurofibromatosis type 1]. (1995) (2)
- Prognostic value of BRAFV600 mutations in American Joint Committee on Cancer (AJCC) stage 3 cutaneous melanoma patients in the MelanCohort prospective cohort. (2015) (2)
- [Hand-foot-mouth syndrome recurring during common variable deficiency]. (1999) (2)
- Nodules on a sternotomy scar. (2015) (2)
- Évaluation du retentissement psychologique de la NET : étude rétrospective de 51 patients (2011) (2)
- Retrospective Outcome Analysis of 39 Patients Who Underwent Lip Surgery for Cutaneous Carcinoma (2016) (2)
- Hemostasis and Type 1 Neurofibromatosis (2017) (2)
- Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts (2021) (2)
- Hemarthrosis: an unusual complication of type 1 neurofibromatosis. (2001) (2)
- Dermatosurgery: Total Quality Management in a Dermatology Department (2012) (2)
- Linear immunoglobulin A disease and vancomycin: letter in reply (2014) (2)
- Acne, the microbiome and innate immunity (2016) (1)
- Self‐diagnosed drug allergies: the belief of patients (2017) (1)
- [Isotretinoin, depression and medias]. (2010) (1)
- Role of lymph-node ultrasonography (US) in the follow-up of melanoma patients to detect nodal recurrence after sentinel lymph node biopsy (SNLB): A prospective cohort study. (2010) (1)
- Abstracts from the 4th World Congress of the International Dermoscopy Society, April 16–18, 2015, Vienna, Austria (2015) (1)
- [Foreign body granuloma on calcified loa loa filariasis]. (1992) (1)
- Randomized double-blind comparison of thalidomide versus placebo in toxic epidermal necrolysis : Overmortality in treated group (1998) (1)
- Essential oils as potential triggers for bullous pemphigoid? A report of two patients (2021) (1)
- [Neglected skin tumors. Three cases]. (2012) (1)
- Respiratory distress with radiographic pleural effusion during measles virus infection (2010) (1)
- Toxidermies médicamenteuses. Diagnostic. (1997) (1)
- Combined therapy Sezary syndrome (2016) (1)
- [18F]FDG Positron emission tomography with whole body magnetic resonance imaging ([18F]FDG-PET/MRI) as a diagnosis tool in Schwannomatosis (2021) (1)
- Purulent Hydradenitis. Part II (1970) (1)
- Clinical Risk Factors for Mortality in Patients With Neurofibromatosis 1 (2015) (1)
- Reply to Kratz et al. (2020) (1)
- Treatment of dissecting cellulitis of the scalp with tumor necrosis factor inhibitors: a retrospective multicenter study. (2023) (1)
- Late diagnosis of neurofibromatosis type 1 in an 81‐year‐old patient (2015) (1)
- Iloprost: a potential alternative for skin graft‐resistant hypertensive leg ulcer (2020) (1)
- Lupus erythematosus and epidermal necrolysis: a case series of 16 patients (2021) (1)
- Bullous pemphigoid: three main clusters defining three outcome profiles. (2022) (1)
- Involvement of small‐diameter nerve fibres in long‐term chronic pain after Stevens–Johnson syndrome or toxic epidermal necrolysis. A neurophysiological assessment (2020) (1)
- Hypothermia related to air-fluidized bed (2005) (1)
- Pityriasis lichenoides: a clinical and pathological case series of 49 patients with an emphasis on follow‐up (2021) (1)
- Skin cancer and COVID‐19: was the diagnosis safeguarded by teledermatology? a study on 1229 cases (2022) (1)
- Abstract PR15: SUZ12: A novel tumor suppressor and potential biomarker for efficacy of BRD4 inhibition (2013) (1)
- Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: Proportion and determinants of underreporting to pharmacovigilance. (2019) (1)
- MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis (2013) (1)
- PSS4 Acne and Lifestyle: Results of a Survey on a Representative Sample of the French Population (2012) (1)
- Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study (2019) (1)
- [Cosmetic dermopigmentation. The pigment stays ... as do regrets]. (1995) (1)
- Quality of life in neurofibromatosis 1: development and validation of a tool dedicated to cutaneous neurofibromas in adults (2022) (1)
- [Management of cutaneous risk in pharmacovigilance: metabolic predisposition to Stevens-Johnson syndromes and toxic epidermal necrolysis]. (1996) (1)
- Cervical cutaneous sclerosis: the stomach is not far from the skin (2019) (0)
- ILDS Newsletter No. 27 (2013) (0)
- Clinical forms of scoliosis associated with type 1 neurofibromatosis: A retrospective study in 35 patients (2011) (0)
- [Non-bacterial thrombotic endocarditis complicating metastatic melanoma]. (1994) (0)
- Drug presentation to T cells. Authors' reply (2005) (0)
- ILDS Newsletter No. 34 (2015) (0)
- Polymorphisms of the MATP/SLC45A2 gene and susceptibility to melanoma in the French population (2008) (0)
- Subject Index Vol. 215, 2007 (2007) (0)
- Safety and efficacy of high-dose clobetasol propionate 0.05% in cutaneous lichen planus. (2022) (0)
- Contents Vol. 228, 2014 (2014) (0)
- Subject Index Vol. 216, 2008 (2008) (0)
- Newsletter No. 7/2009 (2009) (0)
- Isotretinoin, Depression, and the Media (2010) (0)
- Which patients present to dermatologic emergencies? A survey on 1561 patients (2021) (0)
- [Predisposing factors in cutaneous reactions to drugs]. (1995) (0)
- PIN40 PREVALENCE AND QUALITY OF LIFE OF PATIENTS SUFFERING FROM HERPES LABIALIS WITH IN FRANCE—INSTANT STUDY (2003) (0)
- [Transcultural adaptation of levels of quality of life: a need and an emergency for dermatologists]. (2000) (0)
- [An herpes zoster with behavior disorder]. (2012) (0)
- Factors which influence death rates in different types of epidermal necrolysis (drug reactions) (2020) (0)
- cNF-Skindex in adults living with Neurofibromatosis 1: severity strata in France and validation in US adults. (2023) (0)
- Accumulation prolongée de minocycline et DRESS : 9 observations (2004) (0)
- Mechanism of drug eruptions (1998) (0)
- PTSD in SJS/TEN: prevalence and risk factors (2019) (0)
- Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus (2023) (0)
- A study looking at different types of severe rashes called acute exanthemas (2020) (0)
- Acquisition of a slow acetylator phenotype in aids patients with a rapid acetylator genotype: An explanation for high frequency of cutaneous sulfonamides reactions in AIDS population? (1998) (0)
- Saiag, Philippe and Aegerter, Philippe and Vitoux, Dominique and Lebbé, Celeste and Wolkenstein, Pierre and Dupin, Nicolas and Descamps, Vincent and Aractingi, Selim and Funck-Brentano, Elisa and Autier, Philippe and Dragomir, Miruna and Boniol, Mathieu (2015) Prognostic value of 25-hydroxyvitamin (2018) (0)
- Purulent Hidradenitis. Part I (2017) (0)
- Contents Vol. 216, 2008 (2008) (0)
- [The cutaneous drug reaction database]. (1999) (0)
- LB951 Establishing a roadmap for therapeutics development for cutaneous neurofibromas (2017) (0)
- A cooperative effort of the Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology (2015) (0)
- Prise en charge chirurgicale des patients atteints d’hidradénite suppurée (2018) (0)
- Psoriatic triADA, or lost clinical response (2020) (0)
- Atypical bullous dermatosis: from suspected drug reaction to misdiagnosed occult epilepsy. Two challenging cases. (2020) (0)
- ILDS Newsletter No. 18 (2011) (0)
- Newsletter ILDS No. 14 (2010) (0)
- Vitamin D level at diagnosis and its variation during follow-up as prognostic factor of cutaneous melanoma. (2014) (0)
- Schwannomatose segmentaire : une série de 12 patients (2018) (0)
- ILDS Newsletter No. 30 (2013) (0)
- ILDS Newsletter No. 28 (2013) (0)
- Identification of three clinical neurofibromatosis 1 subtypes: Latent class analysis of a series of 1351 patients (2022) (0)
- [Association of pemphigus and Lyell's syndrome]. (1990) (0)
- [The frequency and impact of skin diseases in France]. (2004) (0)
- VEGF and VEGFR family members are expressed by neoplastic cells of NF1-associated tumors and may play an oncogenic role in malignant peripheral nerve sheath tumor growth through an autocrine loop. (2022) (0)
- Ethnicity and skin conditions in Europe: a large survey from the "Burden of Skin Diseases" EADV project. (2023) (0)
- Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes (2018) (0)
- Prevalence and Environmental Risk Factors of Self-Reported Acne in Mexico (2016) (0)
- Novel inflammatory markers and in‐hospital mortality in epidermal necrolysis—A monocentric study of 137 patients (2022) (0)
- French cohort of children and adolescents with neurofibromatosis type 1 and symptomatic inoperable plexiform neurofibromas: CASSIOPEA study. (2023) (0)
- [Molecular diagnosis strategies in neurofibromatosis type 1]. (2019) (0)
- Biases associated with epidermal necrolysis reporting in pharmacovigilance: An exploratory analysis using World Health Organization VigiBase (2021) (0)
- Effectiveness of Surgery in the Management of Neurofibromatosis 1 (Von Recklinghausen Disease) (2010) (0)
- Correction: Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study (2019) (0)
- [Neurofibromatosis: pat and prospects]. (1998) (0)
- Pulmonary Embolism* LungScanning Interpretation: AboutWords (2017) (0)
- Pityriasis lichenoides: relevance of the current classification? (2019) (0)
- ILDS Newsletter No. 32 (2014) (0)
- Preventability of SCARs (2018) (0)
- Treatment of prurigo with methotrexate : a multicenter retrospective study of 39 cases Running head : Treatment of prurigo with methotrexate (2017) (0)
- [Proposed goals of a French Dermatology Society (SFD) public information website]. (2010) (0)
- Health‐related quality of life and long‐term related conditions in survivors of epidermal necrolysis: a study of 57 patients (2020) (0)
- [Cutaneous manifestations of blind-loop syndrome]. (1990) (0)
- Comment on Intragenic inversions in NF1 gene as pathogenic mechanism in neurofibromatosis type 1 (2023) (0)
- 一项探讨称不同类型重度皮疹(急性皮疹)的研究 (2020) (0)
- Levetiracetam : nouvel antiépileptique inducteur de syndrome de Stevens-Johnson ☆ (2011) (0)
- [Quality of life evaluation tools in dermatology]. (1999) (0)
- Manifestations cutanées de l’infection à parvovirus B19 chez l’adulte (2012) (0)
- The role of IL-36γ/IL-1F9 in developing erythroderma in patients with psoriasis (2015) (0)
- Gamma knife radiosurgery is useful in the management of metastatic melanoma in the brain: 397 (1997) (0)
- [Dermatology teaching: professional training in the field of dermatology]. (2013) (0)
- [Pemphigus and herpes: Multicentre survey and literature review]. (2018) (0)
- Neurofibromatosis type 1: Factors associated with flare‐ups of cutaneous neurofibromas at puberty (2022) (0)
- [McCune-Albright syndrome]. (2011) (0)
- [Is systematic excision of pigmented spots on the plantar aspect of the foot warranted?]. (2000) (0)
- Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study (2019) (0)
- Iconography : NEUROFIBROMATOSES ET SCLÉROSE TUBÉREUSE DE BOURNEVILLE (2008) (0)
- P14.33 Adult brainstem gliomas in neurofibromatosis type 1 (NF1) (2019) (0)
- [Dermatology day-care: between official rules and reality]. (2012) (0)
- Contents, Vol. 181, 1990 (1990) (0)
- [Drug-induced toxicoderma. Diagnosis]. (1997) (0)
- Acute generalized exanthematous pustulosis: clinico-biological profile and inducing drugs in 83 patients. (2023) (0)
- Usefulness of patch tests in drug adverse reaction induced by tetrazepam and anti-inflammatory drugs (2014) (0)
- Cholécystite aiguë associée au DRESS : à propos de 3 cas☆ (2014) (0)
- The Heart in Neurofibromatosis 1 (2021) (0)
- University of Groningen Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis (2021) (0)
- 435 IRTEN - An international registry for toxic epidermal necrolysis (2018) (0)
- ILDS Newsletter No. 33 (2014) (0)
- [Neurofibromatosis 1: recommendations for management]. (2002) (0)
- Pharmaceutical formulation stabilized and ready for the use of ivermectin in the treatment of human and animal parasitoses (2015) (0)
- Contents Vol. 215, 2007 (2007) (0)
- Missed Diagnosis of Epilepsy-Associated Scald Burns: Two Cases Initially Diagnosed as Bullous Dermatosis (2020) (0)
- Republication de : Traitement des toxidermies graves (2018) (0)
- Slow acetylator genotype as a metabolic predisposition to sulfonamide-induced toxic epidermal necrolysis (1994) (0)
- FC7 Role of lymph-node ultrasonography (US) in the follow-up of melanoma patients to detect nodal recurrence after sentinel lymph node biopsy (SNLB): a prospective cohort study (2010) (0)
- [Association of chromhidrosis and segmental neurofibromatosis]. (2018) (0)
- Patch testing in drug cutaneous adverse reactions: value of the extemporaneous preparations (2014) (0)
- Clinical images: Necrosis at the tip of the nose in an 83-year-old man. (2011) (0)
- 8-4 – Neurofibromatoses (2017) (0)
- 580 Spontaneous replication stress in Hair Follicle Stem Cells leads to inflammation in Hidradenitis Suppurativa (2019) (0)
- Medical Follow-Up in Neurofibromatosis Type 1 (2020) (0)
- [Misleading and rare form of vulvar carcinoma with fast development. Suspicion of human papillomavirus infection]. (1990) (0)
- MC1R variants and melanoma risk: First study on Melan-Cohort (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Pierre Wolkenstein?
Pierre Wolkenstein is affiliated with the following schools:
